SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-21-038375
Filing Date
2021-03-18
Accepted
2021-03-18 16:23:31
Documents
5
Effectiveness Date
2021-03-18

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm219594-1_s3.htm S-3ASR 299393
2 EXHIBIT 5.1 tm219594d2_ex5-1.htm EX-5.1 33910
3 EXHIBIT 23.1 tm219594d2_ex23-1.htm EX-23.1 3296
4 GRAPHIC lg_trillium-4clr.jpg GRAPHIC 38844
5 GRAPHIC tm219594d2_ex5-1img001.jpg GRAPHIC 4310
  Complete submission text file 0001104659-21-038375.txt   397274
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-254443 | Film No.: 21754628
SIC: 2834 Pharmaceutical Preparations